Upregulated expression of NOP2 predicts worse prognosis of gastric adenocarcinoma by promoting tumor growth

Background: NOP2 nucleolar protein plays a crucial role in early embryo development and cell proliferation. The role of NOP2 in human gastric adenocarcinoma has not been elucidated. In the present study, we aimed to examine the expression levels of NOP2 and dissected whether NOP2 expression was associated with aggressive clinicopathological outcomes of patients with gastric adenocarcinoma. Methods: Clinicopathological analysis was performed in patients with gastric adenocarcinoma. Expression of NOP2 was tested by immunohistochemistry staining and quantitative RT-PCR. The prognostic role of NOP2 in gastric adenocarcinoma patients was assessed by univariate and multivariate analysis. The effect of NOP2 on cell proliferation was examined through cellular experiments and mice models. Results: NOP2 expression was elevated in gastric adenocarcinoma tissues compared to normal gastric tissues. High expression of NOP2 was significantly correlated with tumor size, invasion depth, and lymph node metastasis. Moreover, patients with high NOP2 expression had poorer overall survival, and NOP2 was identified as an independent prognosis factor. Using the gastric adenocarcinoma cells, we found that NOP2 can promote tumor cell proliferation both in vitro and in vivo. Conclusions: Overexpression of NOP2 significantly correlates with a poorer prognosis of gastric adenocarcinoma patients and suggested the potential of NOP2, which may serve as a novel prognostic biomarker in gastric adenocarcinoma.

[1]  Q. Zou,et al.  Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections , 2021, Computers in Biology and Medicine.

[2]  Fan Yang,et al.  FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis , 2021, Oncogene.

[3]  Yuan Li,et al.  Age-Associated Proteomic Signatures and Potential Clinically Actionable Targets of Colorectal Cancer , 2021, Molecular & cellular proteomics : MCP.

[4]  Hongda Liu,et al.  SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma , 2021, Journal of experimental & clinical cancer research : CR.

[5]  G. Wang,et al.  Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma , 2021, Bioengineered.

[6]  Feng Sun,et al.  Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer , 2020, Aging.

[7]  Weihong Li,et al.  Multi-Task Joint Learning Model for Segmenting and Classifying Tongue Images Using a Deep Neural Network , 2020, IEEE Journal of Biomedical and Health Informatics.

[8]  K. Fujinaga,et al.  Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation , 2020, PLoS pathogens.

[9]  Wei Tang,et al.  Tumor origin detection with tissue‐specific miRNA and DNA methylation markers , 2018, Bioinform..

[10]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[11]  Hongda Liu,et al.  Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer. , 2017, Surgical oncology.

[12]  I. Chung,et al.  Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1 , 2016, Development.

[13]  A. Philimonenko,et al.  Nop2 is expressed during proliferation of neural stem cells and in adult mouse and human brain , 2015, Brain Research.

[14]  Fang Wang,et al.  Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell‐like property of hepatocellular carcinoma cells by stabilizing NOP2 , 2014, Hepatology.

[15]  B. Bajorek,et al.  Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy , 2014, Pharmacy practice.

[16]  Hajime Orimo,et al.  [Reviewing the definition of elderly]. , 2006, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[17]  T. Kondo,et al.  Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  L. Montanaro,et al.  p120 expression provides a reliable indication of the rapidity of cell duplication in cancer cells independently of tumour origin , 2000, The Journal of pathology.

[19]  K. Koike,et al.  Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Rifkin,et al.  The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma , 1999, Cancer.

[21]  L. Ventura,et al.  Nucleolar protein p120 expression in oral carcinoma. , 1999, Anticancer research.

[22]  J. Kuratsu,et al.  Expression of p120 nucleolar proliferating antigen in human gliomas and growth suppression of glioma cells by p120 ribozyme vector. , 1999, International journal of oncology.

[23]  T. Abe,et al.  Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  K. Kohno,et al.  Significance of the expression of proliferation-associated nucleolar antigen p120 in human colorectal tumors. , 1997, Human pathology.

[25]  J. Freeman,et al.  Effect of nucleolar P120 expression level on the proliferation capacity of breast cancer cells. , 1994, Cancer research.

[26]  J. Freeman,et al.  Antisense-mediated specific inhibition of P120 protein expression prevents G1- to S-phase transition. , 1992, Cancer research.

[27]  W. Zhang,et al.  Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. , 1992, Cancer research.

[28]  J. Freeman,et al.  Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma. , 1991, Cancer research.

[29]  S. Jhiang,et al.  Expression of human proliferation-associated nucleolar antigen p120. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.